Analysis. Vekuva's measurement of another outlet's report. The reporting is the outlet's; the framing analysis is ours. · Andhra Jyothy
Vekuva’s reading of Andhra Jyothy’s report
క్యాన్సర్ మందుల ధరలకు బ్రేక్ పడలేదా? సుప్రీంకోర్టు ఆదేశించినా మారని 37 ఔషధాల ధరలు!
By ABN2 min read at Andhra Jyothy
In brief
According to the National Pharmaceutical Pricing Authority (NPPA), 37 out of 543 listed cancer drugs have not had their prices reduced despite the Supreme Court's directives.
Health experts noted that merely limiting trade margins offers minimal relief and suggested the government implement compulsory licensing to curb high prices.
This is an AI-estimated analysis and may not reflect the article's actual intent or the publisher's editorial position.
Read this page in English · Google Translate (opens translate.google.com in a new tab)Machine translation by Google, not checked by Vekuva
Home » National » cancer drug prices India NPPA 37 patent medicines avn
ABN , Publish Date - Oct 29 , 2026 | 01:57 PM
That is the opening of Andhra Jyothy’s story. The full report is on their site.
Read the full story at Andhra Jyothy (opens in a new tab)